A5 Laboratories Inc. — Form D
A5 Laboratories Inc. of LACHINE, A8, a company, filed a Form D exempt-offering notice with the SEC on 2011-03-11. The offering totals $2.5M, of which $545K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-03-11
- Form: D
- Accession: 0001144204-11-014134
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $2.5M
- Amount sold: $545K
- Remaining: $2.0M
- Minimum investment: $200K
- Investors: 1
- Date of first sale: 2011-02-23
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-156543
Issuer
- Name: A5 Laboratories Inc.
- CIK: 0001381054
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2006
- Address: 10300 CHEMIN COTE DE LIESSE, LACHINE, A8, H8T1A3
- Phone: (514) 420-0333
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Richard Azani | Director | Lachina, A8 |
| Richard Azani | Executive Officer | Lachina, A8 |
More